Collegium

Collegium is a Massachusetts-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic acute pain.

Business Model:

Revenue: $361.7M

Employees: 51-200

Detailed Collegium Information

Geographic Data

Collegium headquarters map

Address: 100 Technology Center Drive

City: Stoughton

State: MA

Zip: 02072

Country: US

Financial Info

Stage:

private equity

Raised Last:

$50M

Raised Total:

$106M

Metrics

184,572Website Global Rank

428,518Website Monthly Traffic

Twitter Followers

Description

Collegium is a Massachusetts-based specialty pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic acute pain.

Contact Phone:
+17817133699

Contact Email:

Collegium went public on 5/7/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/7/2015

IPO Valuation:
$236M

Ticker Symbol:
COLL

IPO Price:
$12/share

Amount Raised:
$80M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2015 Private Equity Round $0 Eventide
Frazier Healthcare Partners
Adage Capital Management
TPG Biotech
RA Capital Management
Boston Millennia Partners
EcoR1 Capital
Longitude Capital
Skyline Ventures
Aperture Venture Partners
TPG Biotech
Rock Springs Capital
Eventide
Frazier Healthcare Partners
Adage Capital Management
TPG Biotech
RA Capital Management
Boston Millennia Partners
EcoR1 Capital
Longitude Capital
Skyline Ventures
Aperture Venture Partners
TPG Biotech
Rock Springs Capital
2/2020 Post-IPO Debt $200M BioPharma Credit PLC
8/2014 Grant 1 - National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
3/2010 Debt Financing $1M
5/2015 IPO $69.6M
11/2006 Series C $0 Boston Millennia Partners
Westfield Capital Management
Boston Millennia Partners
Westfield Capital Management
10/2016 Secondary Offering $80M
2/2012 Venture Round 4 $22.5M Longitude Capital
Skyline Ventures
Frazier Healthcare Partners
Boston Millennia Partners
Longitude Capital
Skyline Ventures
10/2013 Venture Round $4M
2/2022 Post-IPO Debt $650M BioPharma Credit PLC
11/2018 Post-IPO Equity $20M
10/2003 Series A 1 $3M Boston Millennia Partners
Boston Millennia Partners
7/2008 Series D $0 Frazier Healthcare Partners
Boston Millennia Partners
Westfield Capital Management
Frazier Healthcare Partners
Boston Millennia Partners
Westfield Capital Management
3/2015 Private Equity Round 11 $50M Eventide
Frazier Healthcare Partners
Adage Capital Management
TPG Biotech
RA Capital Management
Boston Millennia Partners
EcoR1 Capital
Longitude Capital
Skyline Ventures
Aperture Venture Partners
TPG Biotech
Eventide
Frazier Healthcare Partners
Adage Capital Management
TPG Biotech
RA Capital Management
Boston Millennia Partners
EcoR1 Capital
Longitude Capital
Skyline Ventures
Aperture Venture Partners
TPG Biotech
8/2014 Grant 1 - National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA)
7/2008 Series D 3 $20M Frazier Healthcare Partners
Frazier Healthcare Partners
11/2006 Series C 2 $5.5M Boston Millennia Partners
Westfield Capital Management
Boston Millennia Partners
Westfield Capital Management
Announced Date Name Price
2/2022 BioDelivery Sciences

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research